Volume 11, Number 10—October 2005
Dispatch
Drug-resistant Escherichia coli, Rural Idaho
Table 3
Healthcare/antimicrobial use in 517 study participants collected from questionnaires and pharmacy data*
| Characteristic | No. (%) |
|---|---|
| Ambulatory visit in past 6 mo | 266 (52) |
| Diabetic | 13 (3) |
| Antimicrobial use in past month | 37 (7) |
| No. outpatient visits (past 6 mo) | |
| 0 | 251 (49) |
| 1 | 125 (49) |
| 2 | 59 (23) |
| 3 | 29 (11) |
| 4 | 14 (5) |
| >5 | 32 (12) |
| No. hospitalizations (past 6 mo) | |
| 0 | 483 (93) |
| 1 | 31 (6) |
| 2 | 2 (0) |
| 3 | 1 (0) |
| No. courses of antimicrobial agents in the past year | |
| 0 | 333 (64) |
| 1 | 91 (18) |
| 2 | 39 (8) |
| 3 | 19 (4) |
| 4 | 16 (3) |
| >5 | 19 (4) |
| Antimicrobial classes, no. with >1 course | |
| TMP/SMZ | |
| Past month | 2 (0.4) |
| Past year | 10 (2) |
| Fluoroquinolones | |
| Past month | 7 (1) |
| Past year | 17 (3) |
| Cephalosporins | |
| Past month | 4 (1) |
| Past year | 37 (7) |
| Penicillin | |
| Past month | 18 (4) |
| Past year | 107 (21) |
| Macrolide | |
| Past month | 3 (1) |
| Past year | 24 (5) |
*TMP/SMZ, trimethoprim/sulfamethoxazole.


